Literature DB >> 26243530

Therapy-related acute myeloid leukemia in autoimmune diseases: caveats and pitfalls.

Rodrigo Lopes da Silva1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26243530     DOI： 10.1007/s11096-015-0173-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  8 in total

Review 1.  The evolving challenge of therapy-related myeloid neoplasms.

Authors:  Jane E Churpek; Richard A Larson
Journal:  Best Pract Res Clin Haematol       Date:  2013-10-01       Impact factor: 3.020

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 3.  Mutations in apoptosis genes: a pathogenetic factor for human disease.

Authors:  L Müllauer; P Gruber; D Sebinger; J Buch; S Wohlfart; A Chott
Journal:  Mutat Res       Date:  2001-07       Impact factor: 2.433

4.  Secondary acute myeloid leukemia arising early after cyclophosphamide treatment.

Authors:  Hayretdin Koklu; Abdurrahman Tufan; Yusuf Erkul; Nalan Akyurek; Ramazan Civelek
Journal:  Int J Clin Pharm       Date:  2015-01-23

5.  Therapy-related leukemia and myelodysplasia: susceptibility and incidence.

Authors:  Giuseppe Leone; Livio Pagano; Dina Ben-Yehuda; Maria Teresa Voso
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

Review 6.  ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships.

Authors:  Alfred Mahr; Caroline Heijl; Guillaume Le Guenno; Mikkel Faurschou
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-02       Impact factor: 4.098

7.  Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.

Authors:  Mikkel Faurschou; Inge Juul Sorensen; Lene Mellemkjaer; Anne Gitte Rasmussen Loft; Bjarne Svalgaard Thomsen; Niels Tvede; Bo Baslund
Journal:  J Rheumatol       Date:  2007-10-15       Impact factor: 4.666

8.  Risks of myeloid malignancies in patients with autoimmune conditions.

Authors:  L A Anderson; R M Pfeiffer; O Landgren; S Gadalla; S I Berndt; E A Engels
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.